Moderna
MRNA
#1135
Rank
NZ$28.90 B
Marketcap
$75.12
Share price
0.43%
Change (1 day)
-56.92%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: NZ$28.90 Billion

As of January 2025 Moderna has a market cap of NZ$28.90 Billion. This makes Moderna the world's 1135th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$28.90 B5.57%
2024NZ$27.38 B-54.33%
2023NZ$59.95 B-44.83%
2022NZ$108.68 B-27.91%
2021NZ$150.76 B163.14%
2020NZ$57.29 B486.18%
2019NZ$9.77 B30.58%
2018NZ$7.48 B

End of Day market cap according to different sources

On Jan 4th, 2025 the market cap of Moderna was reported to be:

NZ$28.90 Billion
by Yahoo Finance info icon info icon
NZ$28.90 Billion
by CompaniesMarketCap info icon info icon
NZ$28.90 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$0.18 B-99.35%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$446.62 B 1,445.06%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.48 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$53.81 B 86.17%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$349.64 B 1,109.57%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NZ$4.38 B-84.83%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$618.24 B 2,038.76%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$5.30 B-81.65%๐Ÿ‡บ๐Ÿ‡ธ USA